Axe Compute Inc. (AGPU) AI Stock Analysis

Axe Compute Inc. provides access to graphics processing unit compute capacity and pursues a digital asset treasury strategy focused on the Aethir token through its Compute Services and Treasury Management segment. It also provides an AI infrastructure cluster. Through its Drug Discovery Services segment, the company applies artificial intelligence to its proprietary biobank of over 150,000 tumor samples and creates proprietary 3D culture models for drug development. Formerly known as Predictive Oncology Inc., the company changed its name to Axe Compute Inc. in December 2025. Incorporated in 2002, the company is based in Pittsburgh, Pennsylvania, and operates with 13 employees.

Revenue contracted at a 5-year CAGR of -36.9% between FY2020 and FY2025. Annual revenue slid from $1.6M in FY2024 to $125,284 in FY2025, representing a 92.3% decrease. Gross margin fell from 49.1% in FY2024 to 42.0% in FY2025, while operating margin worsened to -22688.6%. FY2025 net income stood at -$233.1M. However, trailing twelve months revenue through June 30, 2026, reached $3.3M, aided by quarterly revenue growth of 119772.9% year-over-year. TTM operating margin remained negative at -539.0%, alongside a TTM return on assets of -58.4% and diluted EPS of $13.65.

As of June 30, 2026, Axe Compute held $21.9M in cash and short-term investments alongside total debt of $1.7M, yielding net cash of $20.2M. Shareholders' equity was $34.0M, and total assets were $100.4M. The company reported a current ratio of 1.45 and a debt-to-equity ratio of 0.05. In FY2025, operating cash flow was -$10.0M and free cash flow was -$42.5M, driven by capital expenditures of $32.6M. Share count increased by 499.4% over the past 5 years.

Axe Compute trades at a trailing price-to-sales multiple of 27.3x and an EV-to-revenue ratio of 34.3x, compared to the median of its US-listed Technology peers of 2.8x for price-to-sales. Its trailing P/E ratio is 0.6x, compared to 28.1x for its peer median, while its price-to-book ratio is 3.9x. The stock has delivered a year-to-date return of 7.4% but fell 30.2% over the trailing 12 months, trailing the S&P 500 (SPY) return of 16.8%. Over 5 years, AGPU is down 97.9%, whereas the S&P 500 gained 83.0%.

Wall Street coverage consists of 1 Strong Buy rating, with 0 Buy, Hold, Sell, or Strong Sell ratings. The mean price target is $20.00, representing a 160.4% premium over the last close of $7.68. For the fiscal year ending December 31, 2026, analysts estimate revenue of $60.4M and EPS of -$1.74. For the next fiscal year, 1 analyst projects revenue of $431.3M and EPS of -$0.11. The company beat EPS estimates in 1 of the last 4 quarters, and its next earnings date is November 13, 2026.

This page is an AI-written research summary of Axe Compute Inc. (AGPU). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: AGPU income statement, AGPU balance sheet, AGPU key metrics, AGPU analyst forecast, AGPU chart. See the AGPU stock overview for the latest quote and news.